Cindy Perettie

Cindy Perettie

Executive Vice President and Global Head of Kite

Gilead Sciences
Share
Bringing Business and Global Health, Cindy Perettie, Executive VP of Kite, Shares a Journey of Science and Business to Provide World-class Treatment

With a profound knowledge and interest in science, Cindy Perettie spent many of her working years learning how to apply this to roles in the corporate world. 

Her journey began with Bachelor’s of Science in Biology and a Minor in Chemistry, which allowed her to begin her pursuit of work in research and discovery. 

Her first working role as a Senior Research Associate for the Johns Hopkins University led her down a path to learn more about the business aspects of pharmaceuticals, which led to her current role as the Executive VP of Kite. However, on this path there were many steps to take as Perettie evolved to meet the needs of companies like Chiron Corporation, Genentech, Roche and Foundation Medicine

To fulfil her need for business knowledge, she later underwent a Master’s in Business Administration, which helped form her understanding of the corporate environment and how it aligns with global health and sustainability. 

The key challenges of her current role are twofold as Perettie not only has to engage in commercial activities, but do so without compromising the core mission of delivering treatment to lymphoma patients in the fastest time possible. 

“As a head of a company, there's the challenges of balancing delivery on the business side while ensuring we continue to engage employees and really do what's right, not just for patients but for society,” says Perettie. 

In terms of her role at Kite, she says: “We have been focused on delivering our CAR T therapy, not just at academic medical centres but also closer to where patients live in the community—and that's been a challenge that we’ve tackled over the course of the last year.”

Truly driven by the end goal of Kite, Perettie attributes her greatest inspiration to the patients that she and Kite. The criticality of their illnesses and their ability to tackle their diseases head-on is what makes her want to get to work harder and ensure the best outcomes for them. 

“It requires resilience, so be in it for the long game.”

Read the full story HERE.​​​​​​​

Gilead Sciences (Kite Pharma)
Gilead Sciences (Kite Pharma)
Share

Featured Interviews

Featured

Dr Chris Cross

Neuroradiologist at OCSRI

Oklahoma Cancer Specialists and Research Institute transforms its operations with GE HealthCare’s True PACS system, enhancing workflows and patient care

Read More

Dr. Tim Calahan

CTO at Michigan Medicine

Michigan Medicine CTO Dr Tim Calahan on how the Organisation is Implementing a Cloud Transformation, Moving its Epic Systems off-prem for key Benefits

Read More
We have a vision here at Michigan Medicine to deliver good care and train exceptional physicians, but also deliver that care throughout the State of Michigan.
Dr. Tim Calahan
CTO at Michigan Medicine

Sunil Dadlani

Executive Vice President, Chief Information and Digital Transformation Officer

Atlantic Health System is Pioneering a New Era in Healthcare, Utilising Cutting-Edge Technology and AI to Transform Patient Care and Operational Efficiency

Read More

Mike J. Walker

Executive Director, Global Health & Life Sciences Strategy at Microsoft

Mike J. Walker, Executive Director, Strategy, Health & life sciences at Microsoft on the difference between advising and consulting

Read More

Keith Klintworth

Managing Director at Vitality UK

As one of the global leaders in digital health management, VitalityHealth is revolutionising preventative medicine.

Read More

Dr Chris Cross

Neuroradiologist at OCSRI

Oklahoma Cancer Specialists and Research Institute transforms its operations with GE HealthCare’s True PACS system, enhancing workflows and patient care

Read More